Analysis of immune status in autoimmune diseases treated with Biologics
Phase 4
- Conditions
- Autoimmune diseases
- Registration Number
- JPRN-UMIN000012916
- Lead Sponsor
- Osaka University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
-Complicated with active infectious disease -The Petients who the doctors in charge consider should not enter this study
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Biomarkers in sera and the surface markers on peripheral blood cells mRNA of disease related molecules were analyzed by ELISA,FACS and RT-PCR in autoimmune diseases treated with biologics
- Secondary Outcome Measures
Name Time Method To evaluate efficacy of Biologics -clinical assessment;DAS 28,High sensitivity C-reactive protein etc.